Clinical Practice Session

Lupus Nephritis in Four Acts

November 07, 2019 | 10:30 AM - 12:30 PM

Location: Ballroom A, Walter E. Washington Convention Center

Session Description

Lupus nephritis (LN) remains difficult to manage. Several clinical trials have tested novel therapies with only modestly encouraging results. This session critically examines two strategies to treat LN. In addition, the expanding role of the kidney biopsy in LN management is reviewed. The potential role of viruses in the pathogenesis of lupus is re-examined to see if any new management insights can be gleaned.

Learning Objective(s)

  • Expand the focus of B-cell directed therapies to targets beyond CD20 in LN
  • Explain the role of calcineurin inhibitors in LN
  • Describe novel uses of the kidney biopsy for LN management
  • Assess the role of viruses in the pathogenesis of LN

Learning Pathway(s)

  • Glomerular Diseases
  • Pathology

Moderators

  • Isabelle Ayoub, MD, FASN
  • Liz Lightstone, MBBS, PhD

Presentations

  • Lupus Nephritis: The Expanding Role of the Repeat Kidney Biopsy
    10:30 AM - 11:00 AM
    Ana Malvar, MD
  • Viruses and Autoimmunity
    11:00 AM - 11:30 AM
    Lorraine Harper, MD, PhD
  • Beyond Rituximab: Other B-Cell Targets in Lupus Nephritis
    11:30 AM - 12:00 PM
    Yoe Kie Onno Teng, MD, PhD
  • Where Do Calcineurin Inhibitors Fit in the Management of Lupus Nephritis
    12:00 PM - 12:30 PM
    Tak Mao Daniel Chan, MD, MBBS